This observational study of 8,000 patients from Cleveland Clinic examined weight outcomes following discontinuation of semaglutide or tirzepatide in routine clinical practice. The study tracked patients who had achieved weight loss on GLP-1 receptor agonists or dual GLP-1/GIP receptor agonists and subsequently stopped therapy, measuring the extent of weight recurrence and identifying factors associated with weight maintenance or regain.
The primary finding was that a substantial proportion of patients who discontinued semaglutide or tirzepatide did not experience complete weight recurrence to baseline levels. Patients demonstrated variable responses to medication cessation, with some maintaining significant portions of their achieved weight loss despite stopping pharmacotherapy. The study identified specific patient characteristics and behavioral factors that correlated with improved weight maintenance after drug discontinuation, suggesting that certain patients may retain metabolic benefits or behavioral modifications sufficient to prevent full weight rebound.
Dealing with a condition like this?
Dr. Caplan has worked with 30,000+ patients on conditions like this. A consultation starts with your specific situation — not a generic protocol.
Book a consultation →For prescribing clinicians, these findings have relevance for patient counseling and treatment planning. The data indicate that discontinuation of GLP-1 or GLP-1/GIP agonists does not universally result in complete weight regain, contrary to some patient expectations and prior assumptions about these medication classes. This information may inform discussions about treatment duration, the potential for drug holidays or permanent discontinuation in selected patients, and realistic expectations regarding weight trajectory after stopping therapy. The identification of patient subgroups more likely to maintain weight loss after discontinuation could help guide individualized treatment decisions and identify candidates for drug cessation versus continuation.
? Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What does this new Cleveland Clinic study tell us about stopping GLP-1 medications?
- If I stop taking my GLP-1 medication, will I definitely gain all my weight back?
- How long does the weight loss benefit last after stopping GLP-1 therapy?
- Why might people keep weight off after stopping GLP-1 medications?
- Is it safe to stop GLP-1 medication whenever I want?
- What should I do to prevent weight regain after stopping GLP-1 therapy?
- Does this study mean GLP-1 medications provide a permanent cure for weight gain?
- Can I restart my GLP-1 medication if I do start gaining weight again?
- Who participated in this Cleveland Clinic study?
- Should I plan to be on GLP-1 medication forever?
- Read next
FAQ
What does this new Cleveland Clinic study tell us about stopping GLP-1 medications?
The study of nearly 8,000 patients found that many people who stop semaglutide or tirzepatide do not regain all the weight they lost. This suggests the medications may have longer-lasting effects on metabolism and weight management than previously thought.
If I stop taking my GLP-1 medication, will I definitely gain all my weight back?
No, based on this research, many patients maintain significant weight loss even after stopping their GLP-1 medication. However, weight regain varies between individuals and depends on factors like diet, exercise, and how long you took the medication.
How long does the weight loss benefit last after stopping GLP-1 therapy?
The study suggests benefits can persist, but the exact duration varies by person. Maintaining healthy eating habits and physical activity after stopping the medication appears to help preserve weight loss longer.
Why might people keep weight off after stopping GLP-1 medications?
These medications may create lasting changes in how your body regulates hunger and metabolism. Additionally, the behavioral changes and healthier eating habits you develop while on the medication can continue to work in your favor.
Is it safe to stop GLP-1 medication whenever I want?
You should never stop GLP-1 medication without discussing it with your doctor first. Your physician can help you decide if stopping is appropriate for your situation and create a plan to maintain your results.
What should I do to prevent weight regain after stopping GLP-1 therapy?
Focus on maintaining the dietary and exercise habits you developed while on the medication. Regular physical activity, consistent meal planning, and ongoing medical follow-up are important for sustaining your weight loss.
Does this study mean GLP-1 medications provide a permanent cure for weight gain?
While the study shows encouraging results about weight maintenance, these medications are tools that work best alongside lifestyle changes. They are not a permanent cure, but they may help reset your metabolism in ways that persist after stopping.
Can I restart my GLP-1 medication if I do start gaining weight again?
Many patients successfully restart GLP-1 therapy if needed, and your doctor can advise you on the best approach. The decision depends on your individual health status and whether the medication remains appropriate for your situation.
Who participated in this Cleveland Clinic study?
The study included nearly 8,000 patients from everyday clinical practice who took semaglutide or tirzepatide and then stopped. This real-world sample helps show what actually happens to typical patients, not just those in controlled research settings.
Should I plan to be on GLP-1 medication forever?
There is no one-size-fits-all answer, and this research suggests some people may be able to stop while maintaining benefits. Your doctor can help you determine the right duration of therapy based on your personal health goals and medical history.
